Performance of immunologic responses in predicting viral load suppression - Implications for monitoring patients in resource-limited settings

被引:58
作者
Moore, David M.
Mermin, Jonathan
Awor, Anna
Yip, Benita
Hogg, Robert S.
Montaner, Julio S. G.
机构
[1] US Ctr Dis Control & Prevent, Global AIDS Program, Entebbe, Uganda
[2] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[3] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada
关键词
antiretroviral therapy; developing countries; immunologic monitoring; virologic responses;
D O I
10.1097/01.qai.0000243105.80393.42
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: World Health Organization (WHO) guidelines for the use of antiretroviral therapy (ART) in resource-limited settings state that CD4 cell counts may be used to indicate when ART regimens should be changed because of treatment failure. The performance of immunologic monitoring for this purpose has not been evaluated, however. Methods: Participants aged 18 years from the British Columbia HIV/AIDS Drug Treatment Program who had CD4 cell counts <= 200 cells/mu L or an AIDS diagnosis at baseline had CD4 cell counts measured at 6 and 12 months after treatment initiation. Logistic regression analysis was used to calculate sensitivity, specificity, and positive and negative predictive values for immunologic responses in terms of predicting failure to achieve 2 viral load measurements < 500 copies/mL within I year. Results: Viral load suppression occurred in 674 (60%) of 1125 subjects. Using no increase in CD4 cell counts at 6 months as a definition of treatment failure had a sensitivity of 34%, specificity of 94%, positive predictive value of 75%, and negative predictive value of 71% for predicting failure to achieve virologic suppression. Using 12-month CD4 cell count values, the measurements were 35%, 95%, 79%, and 73%, respectively. Conclusion: immunologic criteria to predict which patients have not achieved virologic suppression results in significant misclassification of therapeutic responses.
引用
收藏
页码:436 / 439
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 2003, SCAL ANT THER RES LT
[2]  
BISSON G, 2006, 13 C RETR OPP INF DE
[3]  
Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8
[4]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[5]   Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy [J].
Hogg, RS ;
Yip, B ;
Chan, KJ ;
Wood, E ;
Craib, KJP ;
O'Shaughnessy, MV ;
Montaner, JSG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20) :2568-2577
[6]  
LAFEUILLADE A, 2004, 15 INT AIDS C BANGK
[7]   The Senegalese government's highly active antiretroviral therapy initiative:: an 18-month follow-up study [J].
Laurent, C ;
Diakhaté, N ;
Gueye, NFN ;
Touré, MA ;
Sow, PS ;
Faye, MA ;
Gueye, M ;
Lanièce, I ;
Kane, CT ;
Liégeois, F ;
Vergne, L ;
Mboup, S ;
Badiane, S ;
Ndoye, I ;
Delaporte, E .
AIDS, 2002, 16 (10) :1363-1370
[8]   Population-based hematologic and immunologic reference values for a healthy Ugandan population [J].
Lugada, ES ;
Mermin, J ;
Kaharuza, F ;
Ulvestad, E ;
Were, W ;
Langeland, N ;
Asjo, B ;
Malamba, S ;
Downing, R .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) :29-34
[9]   Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response [J].
Moore, DM ;
Hogg, RS ;
Chan, K ;
Tyndall, M ;
Yip, B ;
Montaner, JSG .
AIDS, 2006, 20 (03) :371-377
[10]   Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy [J].
Moore, DM ;
Hogg, RS ;
Yip, B ;
Wood, E ;
Tyndall, M ;
Braitstein, P ;
Montaner, JSG .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) :288-293